Celularity Inc
CELUW0.010USD
+0.002+26.83%
종가 02/06, 16:00（ET）시세는 15분 지연됩니다
0.00시가총액
--P/E TTM
자세한 내용은 Celularity Inc 회사
Celularity Inc. is a regenerative and cellular medicine company. It is developing and commercializing advanced biomaterial products and allogeneic, cryopreserved, placental-derived cell therapies, all derived from the postpartum placenta. Its therapeutic programs that target aging-related diseases, including degenerative diseases, cancer, and immune disorders, using mesenchymal-like adherent stromal cells, T-cells engineered with CAR (CAR T-cells), and genetically modified and unmodified natural killer (NK) cells. It develops, manufactures and commercializes advanced biomaterial products derived from structural tissue components of the postpartum placental tissues, including the umbilical cord. Its advanced biomaterials include Celularity Tendon Wrap, FUSE Bone Void Filler and Celularity Placental Matrix. Its advanced biomaterial products include Biovance, Interfyl and Rebound products. Its platform is Celularity IMPACT (Immuno-Modulatory Placental-derived Allogeneic Cell Therapy).
Celularity Inc 정보
종목 코드 CELUW
회사 이름Celularity Inc
상장일May 23, 2019
CEODr. Robert J. (Bob) Hariri, M.D., Ph.D.
직원 수- -
유형Company Warrant
회계 연도 종료- -
주소170 Park Ave
도시FLORHAM PARK
증권 거래소NASDAQ Capital Market Consolidated
국가United States of America
우편 번호07932
전화19087682170
웹사이트https://celularity.com/
종목 코드 CELUW
상장일May 23, 2019
CEODr. Robert J. (Bob) Hariri, M.D., Ph.D.
Celularity Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Joseph Dossantos
Mr. Joseph Dossantos
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Dr. Shiu Fei (Geoffrey) Ling, M.D., Ph.D.
Dr. Shiu Fei (Geoffrey) Ling, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Peter H. Diamandis, M.D.
Dr. Peter H. Diamandis, M.D.
Independent Director
Independent Director
--
--
Mr. John R. Haines
Mr. John R. Haines
Senior Executive Vice President, Chief Administrative Officer, Corporate Secretary
Senior Executive Vice President, Chief Administrative Officer, Corporate Secretary
--
--
Mr. Stephen A. Brigido
Mr. Stephen A. Brigido
President - Degenerative Disease
President - Degenerative Disease
--
--
Ms. Diane L. Parks
Ms. Diane L. Parks
Independent Director
Independent Director
--
--
Dr. Robert J. (Bob) Hariri, M.D., Ph.D.
Dr. Robert J. (Bob) Hariri, M.D., Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Carlos Ramirez
Mr. Carlos Ramirez
Senior Vice President - Investor Relations
Senior Vice President - Investor Relations
--
--
Mr. Vincent Levien
Mr. Vincent Levien
Independent Director
Independent Director
--
--
이름
이름/직위
직위
주식 보유
변동
Mr. Joseph Dossantos
Mr. Joseph Dossantos
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Dr. Shiu Fei (Geoffrey) Ling, M.D., Ph.D.
Dr. Shiu Fei (Geoffrey) Ling, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Peter H. Diamandis, M.D.
Dr. Peter H. Diamandis, M.D.
Independent Director
Independent Director
--
--
Mr. John R. Haines
Mr. John R. Haines
Senior Executive Vice President, Chief Administrative Officer, Corporate Secretary
Senior Executive Vice President, Chief Administrative Officer, Corporate Secretary
--
--
Mr. Stephen A. Brigido
Mr. Stephen A. Brigido
President - Degenerative Disease
President - Degenerative Disease
--
--
Ms. Diane L. Parks
Ms. Diane L. Parks
Independent Director
Independent Director
--
--
수익 분석
기업이 아직 관련 데이터를 공개하지 않았습니다.
기업이 아직 관련 데이터를 공개하지 않았습니다.
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.
주식 보유 통계
마지막 업데이트: Fri, Jan 2
마지막 업데이트: Fri, Jan 2
주주
주주 유형
주주
주주
비율
기타
100.00%
주주
주주
비율
기타
100.00%
주주 유형
주주
비율
기타
100.00%
기관 주식 보유
마지막 업데이트: Mon, Dec 8
마지막 업데이트: Mon, Dec 8
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
24
2.39M
0.00%
--
2025Q3
27
2.39M
0.00%
+8.32K
2025Q2
27
2.38M
0.00%
-98.84K
2025Q1
31
2.48M
0.00%
-2.12M
2024Q4
30
2.60M
0.00%
-201.65K
2024Q3
31
2.80M
0.00%
+233.05K
2024Q2
32
2.67M
0.00%
-17.59K
2024Q1
32
2.68M
0.00%
-2.18M
2023Q4
31
3.99M
0.00%
-554.70K
2023Q3
31
4.57M
0.00%
-939.92K
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Clear Street Group Inc
11.91K
0%
+11.91K
--
Sep 30, 2025
Walleye Capital LLC
835.19K
0%
-14.92K
-1.75%
Sep 30, 2025
Linden Advisors L.P.
550.12K
0%
--
--
Sep 30, 2025
Healthcare Of Ontario Pension Plan
350.00K
0%
--
--
Sep 30, 2025
Peak6 Capital Management LLC
171.36K
0%
--
--
Sep 30, 2025
Davidson Kempner Capital Management LP
150.80K
0%
--
--
Sep 30, 2025
Context Capital Management LLC
150.00K
0%
--
--
Sep 30, 2025
Corient Private Wealth LLC
55.00K
0%
--
--
Sep 30, 2025
EMFO, LLC
50.00K
0%
--
--
Jun 30, 2024
Clear Street LLC
11.91K
0%
--
--
Jun 30, 2025
더 보기
관련 ETF
이름
비율
데이터 없음
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
